Advenchen Laboratories, LLC logo

Advenchen Laboratories, LLC

Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in cancer treatment.

6 employees · est. 2003

VS
Deciphera Pharmaceuticals logo

Deciphera Pharmaceuticals

A member of ONO Group

526 employees · est. 2003 · Waltham, United States

Deciphera Pharmaceuticals is the larger of the two.

Side-by-Side Comparison

Advenchen Laboratories, LLC Deciphera Pharmaceuticals
Founded
2003 2003
Headquarters
Not tracked yet Waltham, United States
Employees
6 526 larger
Industry
Biotechnology, Health Care, Pharmaceutical Not tracked yet
Funding Stage
Series Unknown Acquired
Total Funding
$4.48M $3.54B
Funding Rounds
1 10
Services
Not tracked yet Design and Development of Kinase Inhibitors, Clinical Trials and Studies, Expanded Access Program, Patient Response Improvement Programs
Target Customers
Not tracked yet Patients with Cancer, Healthcare Professionals, Pharmaceutical Partners, Clinical Researchers
Taxonomy
Pharmaceutical Research, Small Molecule Drugs, Kinase Inhibitors, Cancer Treatment, Protein Tyrosine Kinase, Drug Discovery, Anti-tumor Activities, Therapeutic Benefits, Proprietary Drug Development, Novel Therapies Biopharmaceutical, Cancer Treatment, Medicines Development, Switch-control Kinase Inhibitors, Kinase Biology, Drug Discovery, Oncology, Innovation In Medicine, Pharmaceutical Research, Tumor Treatment, Biotech Innovation, Kinase Inhibitor Platform
Website
advenchen.com deciphera.com
Advenchen Laboratories, LLC logo

About Advenchen Laboratories, LLC

Advenchen Laboratories is a boutique pharmaceutical company founded in 2003, specializing in small molecule cancer drug discovery programs. The company's focus on identifying small molecule kinase inhibitors, particularly protein tyrosine kinase (PTK) inhibitors, marks a promising approach to cancer...

Deciphera Pharmaceuticals logo

About Deciphera Pharmaceuticals

Deciphera Pharmaceuticals, under the slogan A member of ONO Group, is a noteworthy player in the biopharmaceutical sector, dedicated to innovating crucial cancer treatments. Established in 2003, the company leverages a proprietary switch-control kinase inhibitor platform that capitalizes on extensiv...

We will tell you when either one moves

BounceWatch watches Advenchen Laboratories, LLC and Deciphera Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Advenchen Laboratories... and Deciphera Pharmaceutic... — by email.

Frequently Asked Questions

Advenchen Laboratories, LLC — Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in cancer treatment.. Deciphera Pharmaceuticals — A member of ONO Group. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Advenchen Laboratories, LLC has raised $4.48M while Deciphera Pharmaceuticals has raised $3.54B.
Advenchen Laboratories, LLC and Deciphera Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Advenchen Laboratories, LLC with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Advenchen Laboratories, LLC on 12 Sep 2024, and Deciphera Pharmaceuticals on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy